Shares in Kronos Bio, a US biotech that has been developing small molecule therapeutics to address cancers and other diseases ...

Moderna (Nasdaq: MRNA) today reported financial results and provided business updates for the first quarter of 2025, which ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bristol Myers Squibb’s (NYSE: BMY) Opdivo ...

Shortly after Robert F Kennedy Jr was sworn in as Secretary of Health and Human Services (HHS), US President Donald Trump ...

US biotech Akari Therapeutics (Nasdaq: AKTX), which is developing novel payload antibody drug conjugates (ADCs), today ...

Shares in US drug major Eli Lilly were a hefty 8% down early Thursday after the Indianapolis firm announced its first quarter financial results and latest guidance for 2025.

According to property advisor Knight Frank, venture capital (VC) funding into the UK life sciences sector reached £1.1 ...

US biotech major Biogen (Nasdaq: BIIB) reported stronger-than-expected earnings for the first quarter of 2025, helped by ...

UK drugmaker GSK ended Tuesday’s trading more than 2% higher after announcing its first-quarter financial results.

UK investment firm Aviva Capital Partners is supporting a major new life sciences expansion in south London, which aims to ...

The US Food and Drug Administration (FDA) has approved Imaavy (nipocalimab-aahu), a human FcRn-blocking monoclonal antibody, ...

UK regulators are set to review a proposed label update for Eisai (TYO: 4523) and Biogen’s (Nasdaq: BIIB) Alzheimer’s drug ...